+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
This treatise for patent prosecutors, litigators, and in-house counsel discusses major court decisions in chemical, biotechnology, and pharmaceutical cases within the context of the current law. It contains an incomparably thorough subject-matter index, a table of cases, a table of statutes and regulations cited, and text and footnote references updated to include extensive cross-references to major Federal Circuit cases.
Main Volume Information
Biotechnology and the Federal Circuit, Second Edition is the only reference work that provides an in-depth consideration of the entire body of Federal Circuit precedent in the rapidly developing area of biotechnology. This treatise integrates the court’s decisions in chemical, biotechnology and pharmaceutical cases with an analysis of the current law. Unique in its detailed discussion of precedent and critical analysis of jurisprudence, patent prosecutors, litigators and in-house counsel alike can count on this treatise for the guidance to navigate through the labyrinth of Federal Circuit biotechnology patent law.
The Second Edition offers full analysis and incisive, expert commentary on recent en banc Federal Circuit and Supreme Court decisions which have rewritten the law applied to biotechnology inventions and altered the basic legal principles governing patentability and infringement. It includes extensive revisions and updates to the original volume and supplements, and encompasses the most recent Federal Circuit precedent, including comprehensive analysis and discussion of:
Biotechnology and the Federal Circuit, Second Edition also contains incomparable research aids, including the most thorough subject-matter index available; a completely revised table of cases, and a table of statutes and regulations cited; and text and footnote references updated to include extensive cross-references to recent Federal Circuit cases.
The 2013 Supplement encompasses full analysis of recent Supreme Court and Federal Circuit decisions. It addresses the metes and bounds of patent-eligible subject matter, including:
The 2013 Supplement also:
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).